InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Browse the full record of transactions filed by WIERENGA WENDELL, Director. Officer active across 3 companies, notably Dermata Therapeutics, Inc.. In total, 8 reports have been recorded. History available since 7 April 2022. The latest transaction was disclosed on 27 May 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
8 of 8 declarations
Wendell Wierenga is a Director at Dermata Therapeutics, Inc. He contributes to overseeing the company's operations and formulating strategies. His experience is valuable for the development of the organization.